Warning
This job advert has expired and applications have closed.
Clinical Fellow in Transcatheter Valve Intervention
| Posting date: | 13 June 2024 |
|---|---|
| Salary: | £63,152.00 per year |
| Additional salary information: | £63152.00 a year |
| Hours: | Full time |
| Closing date: | 26 June 2024 |
| Location: | Leeds, LS1 3EX |
| Company: | NHS Jobs |
| Job type: | Contract |
| Job reference: | C9298-MED-530 |
Summary
This appointment will be based at the West Yorkshire Heart Centre, Leeds General Infirmary. Leeds General Infirmary is the largest tertiary cardiac centre in the United Kingdom, providing services to a population of 2.8 million in West Yorkshire, with supra-regional services to the broader population of Yorkshire & Humber, constituting 5.8 million. The cardiology department consists of 2 inpatient wards (one acute admissions ward), a day case interventional ward, a day case radial lounge, 6 lab catheter suite and a 10 bed coronary care unit. Leeds is a high volume PCI centre performing 2200 PCI per annum, of which 1100 are primary PCI maintaining the centres status as the busiest PPCI centre in the UK. The transcatheter valve intervention programme in Leeds is delivered by four interventional cardiologists: Professor Dan Blackman, Dr Chris Malkin, Dr Mike Cunnington, and Dr Noman Ali. This Fellowship would be focussed on transcatheter valve intervention, in particular transcatheter aortic valve implantation (TAVI). Leeds performs approximately 500 TAVI procedures annually. Currently Evolut FX, SAPIEN 3 Ultra, and Navitor valves are used. Standard TAVI procedures are performed under local anaesthetic. More than 95% of procedures are trans-femoral, with percutaneous axillary access the alternate access route of choice. Leeds has a strong record of innovation in TAVI, having been the first centre in the UK to use Lotus, undertaken the first-in-human Evolut study, the first-in-human Triguard cerebral embolic protection study, and been at the forefront of cerebral embolic protection and subclavian/axillary access. We are one of only two centres in the UK currently performing TAVI cases with Jena Trilogy Valve for aortic regurgitation. There is an active research programme supported by 4 research nurses, with multiple peer-reviewed publications in the field. Leeds has an established mitral intervention programme, and is the sole centre for provision of trans-catheter edge to edge repair (TEER) for the 5.8 million population of Yorkshire & Humber, with approximately 50 procedures expected to be performed annually. Leeds has also been involved in trials of a number of novel trans-catheter mitral valve repair and replacement devices including Intrepid, High-Life, Carillon, and Millipede. We also perform mitral valvuloplasty, TAVI-in-mitral valve / ring procedures, paravalvular leak closures, and we are about to start a tricuspid TEER programme. The post is fixed term for one year, expected start date 1st November 2024.